Login/Sign Up
₹495
(Inclusive of all Taxes)
Get Free delivery (₹99) with
Mirasmart 50 PR Tablet is primarily used to treat overactive bladder (OAB) symptoms. Overactive bladder is a condition in which the urinary bladder muscles constrict uncontrollably, thereby causing an urgent need to urinate, frequent urination, and an inability to control urination.
Mirasmart 50 PR Tablet contains ‘mirabegron’ that relaxes the urinary bladder muscles, which in turn decreases the activity of the overactive bladder. Mirasmart 50 PR Tablet stops these sudden contractions of urinary bladder muscles, thereby enabling control over urination.
In some cases, Mirasmart 50 PR Tablet may cause common side effects such as nausea, constipation, diarrhoea, headache, dizziness, and increased heart rate. Most of these side effects do not require medical attention and resolve gradually over time. However, if the side effects persist or worsen, consult a doctor.
Do not take Mirasmart 50 PR Tablet if you are allergic to any of its ingredients. Before taking Mirasmart 50 PR Tablet , inform your doctor if you have kidney disease, liver disease, hypertension, urinary retention, angioedema, or a history of heart rhythm problems (including QT prolongation). Consult your doctor if you are pregnant or breastfeeding.
Mirasmart 50 PR Tablet used in the treatment of overactive bladder. The detailed uses of Mirasmart 50 PR Tablet are as follows:
Unsafe
Avoid taking alcohol as it increases the risk of side effects.
Consult your doctor
Mirasmart 50 PR Tablet is not recommended for use in pregnant women unless absolutely necessary. Before taking this medicine, the risks and benefits should be discussed with the doctor.
Consult your doctor
Mirasmart 50 PR Tablet is not recommended for use in breastfeeding women unless absolutely necessary. Before taking this medicine, the risks and benefits should be discussed with the doctor.
Caution
The use of this medicine may cause blurred vision or dizziness in some patients. You are advised not to perform any activities, such as driving a vehicle or operating machinery, if you experience any of these symptoms during treatment with this medicine.
Caution
Mirasmart 50 PR Tablet should be used with caution in patients with severe liver disease. A dose adjustment of Mirasmart 50 PR Tablet may be needed. Please consult your doctor. Mirasmart 50 PR Tablet is not recommended for use in patients with severe liver disease.
Caution
Mirasmart 50 PR Tablet should be used with caution in patients with kidney disease. A dose adjustment of Mirasmart 50 PR Tablet may be needed. Please consult your doctor.
Unsafe
Mirasmart 50 PR Tablet should not be used in children below 12 years of age unless prescribed by a doctor.
Unsafe
Mirasmart 50 PR Tablet is not recommended in cardiac patients due to its adverse effects. However, if prescribed extreme caution should be exercised.
Safe if prescribed
Mirasmart 50 PR Tablet is safe for use in elderly patients if prescribed by the physician.
Have a query?
Drug-Drug Interactions: Mirasmart 50 PR Tablet may interact with other antifungal drugs (ketoconazole and itraconazole), antihypertensives (carvedilol, metoprolol), antacids (brexpiprazole), anti-psychotics (pimozide, thioridazine), anti-allergic (chlorpheniramine), anti-tussive (dextromethorphan), blood thinners (warfarin, coumadin), anti-depressants (desipramine), anti-arrhythmic (digoxin, flecainide, propafenone), drugs used to treat overactive bladder (darifenacin, fesoterodine, oxybutynin, tolterodine, trospium).
Drug-Food Interactions: Do not take grapefruit or grapefruit juice while using Mirasmart 50 PR Tablet .
Drug-Disease Interactions: Mirasmart 50 PR Tablet should be used with caution in patients with urinary retention (inability to urinate), heart rhythm problems (including QT prolongation), hypertension, kidney dialysis, severe liver disease, or severe kidney disease.
Login/Sign Up
Login/Sign Up
Aristo Pharmaceuticals Pvt Ltd
₹203
(₹20.3 per unit)
Alembic Pharmaceuticals Ltd
₹299
(₹29.9 per unit)
Koye Pharmaceuticals Pvt Ltd
₹300
(₹30.0 per unit)
Disclaimer

RX
RX
RX